AAAAAA

   
Results: 1-25 | 26-36 |
Results: 26-36/36
RISK-BENEFIT RATIO OF APROTININ THERAPY IN CORONARY-ARTERY BYPASS-SURGERY
Authors: VANDERMEER J HILLEGE HL ASCOOP CAPL DUNSELMAN PHJM MULDER BJM PFISTERER M
Citation: J. Vandermeer et al., RISK-BENEFIT RATIO OF APROTININ THERAPY IN CORONARY-ARTERY BYPASS-SURGERY, Circulation, 90(4), 1994, pp. 640-640
EFFECTS OF SPINAL-CORD STIMULATION ON MYOCARDIAL-ISCHEMIA DURING DAILY-LIFE IN PATIENTS WITH SEVERE CORONARY-ARTERY DISEASE - A PROSPECTIVEAMBULATORY ELECTROCARDIOGRAPHIC STUDY - ABSTRACTS
Authors: DEJONGSTE MJL HAAKSMA J HAUTVAST RWM HILLEGE HL MEYLER PWJ STAAL MJ SANDERSON JE LIE KI
Citation: Mjl. Dejongste et al., EFFECTS OF SPINAL-CORD STIMULATION ON MYOCARDIAL-ISCHEMIA DURING DAILY-LIFE IN PATIENTS WITH SEVERE CORONARY-ARTERY DISEASE - A PROSPECTIVEAMBULATORY ELECTROCARDIOGRAPHIC STUDY - ABSTRACTS, British Heart Journal, 71(5), 1994, pp. 413-418
SERIAL ANGIOSCOPIC AND ANGIOGRAPHIC OBSERVATIONS DURING THE FIRST HOUR AFTER SUCCESSFUL CORONARY ANGIOPLASTY - A PREAMBLE TO A MULTICENTER TRIAL ADDRESSING ANGIOSCOPIC MARKERS FOR RESTENOSIS
Authors: DENHEIJER P VANDIJK RB HILLEGE HL PENTINGA ML SERRUYS PW LIE KI
Citation: P. Denheijer et al., SERIAL ANGIOSCOPIC AND ANGIOGRAPHIC OBSERVATIONS DURING THE FIRST HOUR AFTER SUCCESSFUL CORONARY ANGIOPLASTY - A PREAMBLE TO A MULTICENTER TRIAL ADDRESSING ANGIOSCOPIC MARKERS FOR RESTENOSIS, The American heart journal, 128(4), 1994, pp. 656-663
LOW-DOSE ASPIRIN (50 MG A DAY), ALONE OR WITH DIPYRIDAMOLE, AND ORAL ANTICOAGULANTS AFTER INTERNAL MAMMARY ARTERY BYPASS-GRAFTING - SIMILARITY IN ONE-YEAR GRAFT PATENCY DIFFERENCES IN CLINICAL OUTCOME
Authors: VANDERMEER J HILLEGE HL VANGILST WH
Citation: J. Vandermeer et al., LOW-DOSE ASPIRIN (50 MG A DAY), ALONE OR WITH DIPYRIDAMOLE, AND ORAL ANTICOAGULANTS AFTER INTERNAL MAMMARY ARTERY BYPASS-GRAFTING - SIMILARITY IN ONE-YEAR GRAFT PATENCY DIFFERENCES IN CLINICAL OUTCOME, Thrombosis and haemostasis, 69(6), 1993, pp. 635-635
VEIN GRAFT PATENCY AND CLINICAL OUTCOME ONE-YEAR AFTER CORONARY-BYPASS SURGERY IN PATIENTS TREATED WITH ASPIRIN (50 MG A DAY), ASPIRIN PLUSDIPYRIDAMOLE, OR ORAL ANTICOAGULANTS - RESULTS OF A PROSPECTIVE, RANDOMIZED TRIAL
Authors: VANDERMEER J HILLEGE HL VANGILST WH
Citation: J. Vandermeer et al., VEIN GRAFT PATENCY AND CLINICAL OUTCOME ONE-YEAR AFTER CORONARY-BYPASS SURGERY IN PATIENTS TREATED WITH ASPIRIN (50 MG A DAY), ASPIRIN PLUSDIPYRIDAMOLE, OR ORAL ANTICOAGULANTS - RESULTS OF A PROSPECTIVE, RANDOMIZED TRIAL, Thrombosis and haemostasis, 69(6), 1993, pp. 636-636
LEVEL OF ORAL ANTICOAGULATION FOR THE 1ST YEAR AFTER CORONARY-BYPASS SURGERY IS NO PREDICTOR OF ONE-YEAR VEIN GRAFT PATENCY
Authors: VANDERMEER J HILLEGE HL VANGILST WH
Citation: J. Vandermeer et al., LEVEL OF ORAL ANTICOAGULATION FOR THE 1ST YEAR AFTER CORONARY-BYPASS SURGERY IS NO PREDICTOR OF ONE-YEAR VEIN GRAFT PATENCY, Thrombosis and haemostasis, 69(6), 1993, pp. 674-674
RISK OF THROMBOEMBOLISM DURING PREGNANCY AND PUERPERIUM IN PROTEIN-C DEFICIENT WOMEN
Authors: HENKENS CMA HILLEGE HL VANDERSCHAAF W BOM VJJ VANDERMEER J
Citation: Cma. Henkens et al., RISK OF THROMBOEMBOLISM DURING PREGNANCY AND PUERPERIUM IN PROTEIN-C DEFICIENT WOMEN, Thrombosis and haemostasis, 69(6), 1993, pp. 713-713
PREVENTION OF ONE-YEAR VEIN-GRAFT OCCLUSION AFTER AORTOCORONARY-BYPASS SURGERY - A COMPARISON OF LOW-DOSE ASPIRIN, LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE, AND ORAL ANTICOAGULANTS
Authors: VANDERMEER J HILLEGE HL KOOTSTRA GJ ASCOOP CAPL PFISTERER M VANGILST WH LIE KI
Citation: J. Vandermeer et al., PREVENTION OF ONE-YEAR VEIN-GRAFT OCCLUSION AFTER AORTOCORONARY-BYPASS SURGERY - A COMPARISON OF LOW-DOSE ASPIRIN, LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE, AND ORAL ANTICOAGULANTS, Lancet, 342(8866), 1993, pp. 257-264
ONE-YEAR VEIN CORONARY-BYPASS GRAFT PATENCY IN PATIENTS TREATED WITH COUMARINS IS NOT RELATED TO THE LEVEL OF ANTICOAGULATION
Authors: VANDERMEER J HILLEGE HL
Citation: J. Vandermeer et Hl. Hillege, ONE-YEAR VEIN CORONARY-BYPASS GRAFT PATENCY IN PATIENTS TREATED WITH COUMARINS IS NOT RELATED TO THE LEVEL OF ANTICOAGULATION, Circulation, 88(4), 1993, pp. 516-516
TORSADES-DE-POINTES WITH ALMOKALANT, A NEW CLASS-III ANTIARRHYTHMIC DRUG
Authors: WIESFELD ACP CRIJNS HJGM BERGSTRAND RH ALMGREN O HILLEGE HL LIE KI
Citation: Acp. Wiesfeld et al., TORSADES-DE-POINTES WITH ALMOKALANT, A NEW CLASS-III ANTIARRHYTHMIC DRUG, The American heart journal, 126(4), 1993, pp. 1008-1011
ELECTROCARDIOGRAPHIC PATTERNS RELATIVE TO INITIATING MECHANISMS OF EXERCISE-INDUCED VENTRICULAR-TACHYCARDIA
Authors: TUININGA YS CRIJNS HJGM WIESFELD ACP VANVELDHUISEN DJ HILLEGE HL LIE KI
Citation: Ys. Tuininga et al., ELECTROCARDIOGRAPHIC PATTERNS RELATIVE TO INITIATING MECHANISMS OF EXERCISE-INDUCED VENTRICULAR-TACHYCARDIA, The American heart journal, 126(2), 1993, pp. 359-367
Risultati: 1-25 | 26-36 |